| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.6 |
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | -0.088 | 0.6 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | 0.027 | 0.6 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | -0.017 | 0.6 |